Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoel Lubell

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Plos One|May 23, 2017
Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web applicationSai Thein Than Tun, Yoel Lubell, Arjen M Dondorp, et al.
Antimicrobial Resistance and Infection Control|August 18, 2018
Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their usePoojan Shrestha, Ben S Cooper, Joanna Coast, et al.
PLOS Global Public Health|November 8, 2021
Antimicrobial resistance detection in Southeast Asian hospitals is critically important from both patient and societal perspectives, but what is its cost?Tamalee Roberts, Nantasit Luangasanatip, Clare L Ling, et al.
Healthcare in Low-Resource Settings|February 9, 2024
The impact of C-reactive protein testing on treatment-seeking behavior and patients' attitudes toward their care in Myanmar and ThailandRachel C Greer, Thomas Althaus, Sabine Dittrich, et al.
PLOS Global Public Health|August 21, 2023
Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid testArjun Chandna, Raman Mahajan, Priyanka Gautam, et al.
Plos One|March 31, 2016
Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical SettingsYoel Lubell, Thomas Althaus, Stuart D Blacksell, et al.
Malaria Journal|December 28, 2019
Economic considerations support C-reactive protein testing alongside malaria rapid diagnostic tests to guide antimicrobial therapy for patients with febrile illness in settings with low malaria endemicityYoel Lubell, Arjun Chandna, Frank Smithuis, et al.
International Health|January 29, 2011
The role of mathematical modelling in guiding the science and economics of malaria eliminationRichard J Maude, Yoel Lubell, Duong Socheat, et al.
BMC Infectious Diseases|February 6, 2016
Accuracy of commercially available c-reactive protein rapid tests in the context of undifferentiated fevers in rural LaosKoukeo Phommasone, Thomas Althaus, Phonesavanh Souvanthong, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 15, 2015
Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in ThailandViriya Hantrakun, Wirongrong Chierakul, Ploenchan Chetchotisakd, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Plos One|May 23, 2017
Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web applicationSai Thein Than Tun, Yoel Lubell, Arjen M Dondorp, et al.
Antimicrobial Resistance and Infection Control|August 18, 2018
Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their usePoojan Shrestha, Ben S Cooper, Joanna Coast, et al.
PLOS Global Public Health|November 8, 2021
Antimicrobial resistance detection in Southeast Asian hospitals is critically important from both patient and societal perspectives, but what is its cost?Tamalee Roberts, Nantasit Luangasanatip, Clare L Ling, et al.
Healthcare in Low-Resource Settings|February 9, 2024
The impact of C-reactive protein testing on treatment-seeking behavior and patients' attitudes toward their care in Myanmar and ThailandRachel C Greer, Thomas Althaus, Sabine Dittrich, et al.
PLOS Global Public Health|August 21, 2023
Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid testArjun Chandna, Raman Mahajan, Priyanka Gautam, et al.
Plos One|March 31, 2016
Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical SettingsYoel Lubell, Thomas Althaus, Stuart D Blacksell, et al.
Malaria Journal|December 28, 2019
Economic considerations support C-reactive protein testing alongside malaria rapid diagnostic tests to guide antimicrobial therapy for patients with febrile illness in settings with low malaria endemicityYoel Lubell, Arjun Chandna, Frank Smithuis, et al.
International Health|January 29, 2011
The role of mathematical modelling in guiding the science and economics of malaria eliminationRichard J Maude, Yoel Lubell, Duong Socheat, et al.
BMC Infectious Diseases|February 6, 2016
Accuracy of commercially available c-reactive protein rapid tests in the context of undifferentiated fevers in rural LaosKoukeo Phommasone, Thomas Althaus, Phonesavanh Souvanthong, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|May 15, 2015
Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in ThailandViriya Hantrakun, Wirongrong Chierakul, Ploenchan Chetchotisakd, et al.
Pageof 13